Literature DB >> 3826461

Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures.

B M Nkowane, S W Bart, W A Orenstein, M Baltier.   

Abstract

An outbreak of measles occurred in a high school with a documented vaccination level of 98 per cent. Nineteen (70 per cent) of the cases were students who had histories of measles vaccination at 12 months of age or older and are therefore considered vaccine failures. Persons who were unimmunized or immunized at less than 12 months of age had substantially higher attack rates compared to those immunized on or after 12 months of age. Vaccine failures among apparently adequately vaccinated individuals were sources of infection for at least 48 per cent of the cases in the outbreak. There was no evidence to suggest that waning immunity was a contributing factor among the vaccine failures. Close contact with cases of measles in the high school, source or provider of vaccine, sharing common activities or classes with cases, and verification of the vaccination history were not significant risk factors in the outbreak. The outbreak subsided spontaneously after four generations of illness in the school and demonstrates that when measles is introduced in a highly vaccinated population, vaccine failures may play some role in transmission but that such transmission is not usually sustained.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826461      PMCID: PMC1646939          DOI: 10.2105/ajph.77.4.434

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Present status of measles and rubella immunization in the United States: a medical progress report.

Authors:  S Krugman
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

2.  IMMUNIZATION AGAINST MEASLES: DEVELOPMENT AND EVALUATION OF A HIGHLY ATTENUATED LIVE MEASLES VACCINE.

Authors:  A J SCHWARZ
Journal:  Ann Paediatr       Date:  1964

Review 3.  Measles vaccine failure. A survey of causes and means of prevention.

Authors:  G F Hayden
Journal:  Clin Pediatr (Phila)       Date:  1979-03       Impact factor: 1.168

4.  Measles in children previously vaccinated against measles.

Authors:  S J Lerman; E Gold
Journal:  JAMA       Date:  1971-05-24       Impact factor: 56.272

5.  Development and evaluation of the Moraten measles virus vaccine.

Authors:  M R Hilleman; E B Buynak; R E Weibel; J Stokes; J E Whitman; M B Leagus
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

6.  Field evaluation of vaccine efficacy.

Authors:  W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines.

Authors:  R E Weibel; E B Buynak; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-11

8.  Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination.

Authors:  J D Shelton; J E Jacobson; W A Orenstein; K F Schulz; H D Donnell
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

9.  Further-attenuated measles vaccine: characteristics and use.

Authors:  S Krugman
Journal:  Rev Infect Dis       Date:  1983 May-Jun

10.  Antibody response following measles-mumps-rubella vaccine under conditions of customary use.

Authors:  P A Brunell; K Weigle; M D Murphy; Z Shehab; E Cobb
Journal:  JAMA       Date:  1983-09-16       Impact factor: 56.272

View more
  25 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  An event-based model of superspreading in epidemics.

Authors:  Alex James; Jonathan W Pitchford; Michael J Plank
Journal:  Proc Biol Sci       Date:  2007-03-07       Impact factor: 5.349

3.  New York State's two-dose schedule for measles immunization.

Authors:  G S Birkhead; D L Morse; I J Mills; L F Novick
Journal:  Public Health Rep       Date:  1991 May-Jun       Impact factor: 2.792

4.  A measles outbreak at a college with a prematriculation immunization requirement.

Authors:  B S Hersh; L E Markowitz; R E Hoffman; D R Hoff; M J Doran; J C Fleishman; S R Preblud; W A Orenstein
Journal:  Am J Public Health       Date:  1991-03       Impact factor: 9.308

5.  Elimination of measles in the Americas.

Authors:  J Furesz
Journal:  CMAJ       Date:  1996-11-15       Impact factor: 8.262

6.  MMR Vaccine: When Is the Right Time for the Second Dose?

Authors:  Oscar R Herrera; Terrika A Thornton; Richard A Helms; Stephan L Foster
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

7.  The role of secondary vaccine failures in measles outbreaks.

Authors:  R G Mathias; W G Meekison; T A Arcand; M T Schechter
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

8.  Measles hospitalizations, United States, 1977-84: comparison with national surveillance data.

Authors:  L E Markowitz; A Tomasi; B I Sirotkin; R W Carr; R M Davis; S R Preblud; W A Orenstein
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

9.  Revaccination of children during school-based measles outbreaks: potential impact of a new policy recommendation.

Authors:  J W Osterman; D Melnychuk
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

10.  Duration of the immune response to MMR vaccine in children of two age-different groups.

Authors:  S Li Volti; G Giammanco-Bilancia; M Grassi; R Garozzo; R Gluck; G Giammanco
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.